12:00 AM
 | 
Feb 07, 2011
 |  BC Week In Review  |  Company News  |  Deals

iPierian, Kyoto University deal

iPierian assigned to the university its patents, patent applications and IP related to its induced pluripotent stem cells (iPSC) technology. In return, iPierian will receive a non-exclusive license to a combined patent...

Read the full 138 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >